453 related articles for article (PubMed ID: 32041110)
1. Current Biomedical Use of Copper Chelation Therapy.
Baldari S; Di Rocco G; Toietta G
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041110
[TBL] [Abstract][Full Text] [Related]
2. Selective divalent copper chelation for the treatment of diabetes mellitus.
Cooper GJ
Curr Med Chem; 2012; 19(17):2828-60. PubMed ID: 22455587
[TBL] [Abstract][Full Text] [Related]
3. Copper in medicine: homeostasis, chelation therapy and antitumor drug design.
Wang T; Guo Z
Curr Med Chem; 2006; 13(5):525-37. PubMed ID: 16515519
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
Cooper GJ
Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
[TBL] [Abstract][Full Text] [Related]
5. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
6. Copper chelation as an antiangiogenic therapy.
Lowndes SA; Harris AL
Oncol Res; 2004; 14(11-12):529-39. PubMed ID: 15666995
[TBL] [Abstract][Full Text] [Related]
7. Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.
Zhong G; Wang X; Li J; Xie Z; Wu Q; Chen J; Wang Y; Chen Z; Cao X; Li T; Liu J; Wang Q
Curr Neuropharmacol; 2024; 22(10):1650-1671. PubMed ID: 38037913
[TBL] [Abstract][Full Text] [Related]
8. Prochelator strategies for site-selective activation of metal chelators.
Oliveri V; Vecchio G
J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
[TBL] [Abstract][Full Text] [Related]
9. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
Davies KM; Mercer JF; Chen N; Double KL
Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
[TBL] [Abstract][Full Text] [Related]
10. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Delangle P; Mintz E
Dalton Trans; 2012 Jun; 41(21):6359-70. PubMed ID: 22327203
[TBL] [Abstract][Full Text] [Related]
11. The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators.
Zheng Y; Li XK; Wang Y; Cai L
Hemoglobin; 2008; 32(1-2):135-45. PubMed ID: 18274991
[TBL] [Abstract][Full Text] [Related]
12. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Giampietro R; Spinelli F; Contino M; Colabufo NA
Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
[TBL] [Abstract][Full Text] [Related]
13. Control of copper status for cancer therapy.
Goodman VL; Brewer GJ; Merajver SD
Curr Cancer Drug Targets; 2005 Nov; 5(7):543-9. PubMed ID: 16305350
[TBL] [Abstract][Full Text] [Related]
14. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up.
Larnaout A; Ammar N; Mourad Z; Naji S; Hentati F
Neuropediatrics; 2008 Jun; 39(3):176-8. PubMed ID: 18991198
[TBL] [Abstract][Full Text] [Related]
16. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
18. Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs.
Tosato M; Di Marco V
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31324037
[TBL] [Abstract][Full Text] [Related]
19. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
20. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
